Key enzyme in urea synthesis is:
## **Core Concept**
The synthesis of urea, also known as the urea cycle or ornithine cycle, is a critical process by which the body disposes of excess nitrogen. This process primarily occurs in the liver and involves a series of biochemical reactions that convert ammonia into urea, which is then excreted. The key enzymes in this pathway play essential roles in catalyzing these reactions.
## **Why the Correct Answer is Right**
The correct answer, **carbamoyl phosphate synthetase I (CPS I)**, is a crucial enzyme in the urea cycle. It catalyzes the synthesis of carbamoyl phosphate from ammonia, carbon dioxide, and ATP. This reaction is the rate-limiting step of the urea cycle and is essential for the initiation of the cycle. Carbamoyl phosphate synthetase I is unique to the liver and is located in the mitochondria, where it facilitates the conversion of ammonia into a less toxic form, urea.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while it might represent an enzyme involved in some metabolic pathway, it is not specified and does not directly relate to the well-known key enzymes in the urea cycle.
- **Option B:** This option is incorrect because, although it seems to represent another enzyme, without specification, it's hard to directly refute, but **arginase** is indeed an enzyme in the urea cycle, catalyzing the final step where arginine is converted into urea and ornithine. However, it's not considered the key or rate-limiting enzyme.
- **Option C:** This option is incorrect because, similar to Option A, without a specific enzyme mentioned, it's difficult to assess directly, but it's not recognized as a key enzyme in the urea cycle.
- **Option D:** This option is incorrect because, again, without specification, it does not directly correspond to a well-recognized key enzyme in the urea cycle.
## **Clinical Pearl / High-Yield Fact**
A critical clinical pearl is that deficiencies or impairments in the enzymes of the urea cycle, such as carbamoyl phosphate synthetase I, can lead to hyperammonemia, a condition characterized by elevated levels of ammonia in the blood. This condition can result in severe neurological symptoms and is a medical emergency.
## **Correct Answer:** . carbamoyl phosphate synthetase I.